Drug Choice Particularly Important In Medicare Population – PhRMA Study
This article was originally published in The Pink Sheet Daily
Executive Summary
A PhRMA-sponsored study of ACE inhibitor, SSRI and insulin labels examined differences within the classes, including indication, route of elimination and interactions. Drug variations and characteristics of the elderly population make flexibility particularly important when designing formularies for the Medicare drug benefit, the study concludes.